Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Vermillion to Report Second Quarter 2017 Financial Results and Host Investor Conference Call on August 8th

Vermillion
Posted on: 29 Jul 17

AUSTIN, Texas, July 27, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that it will report its second quarter 2017 financial results on Tuesday, August 8, 2017, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.

Tuesday, August 8th @ 4:30pm Eastern Time

Domestic:

888-437-9274

International:

719-325-2437

Conference ID:

8515049

Webcast:

http://public.viavid.com/index.php?id=125153


 

Replays, Available through August 22nd

Domestic:

844-512-2921

International:

412-317-6671

Replay PIN:

8515049

About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases.

Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
646-597-6983
mwood@lifesciadvisors.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 29/07/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.